Private Equity
Synopsys Inc. has acquired Synfora Inc., a Mountain View, Calif.-based provider of algorithmic synthesis tools for IC and system designers. No financial terms were disclosed. Synfora has raised around $27 million in VC funding, from firms like ATA Ventures, Foundation Capital, Wafra Partners, Xilinx and U.S. Venture Partners.
2 min read · 11 June 2010
TeamSnap, a Boulder, Colo.-based provider of an online service to manage sports teams and other groups, has raised $700,000 in first-round funding from eonBusiness and individual angels.
2 min read · 11 June 2010
Inotek Pharmaceuticals Corp., a Beverly, Mass.-based drug development company, has raised $18 million in fourth-round funding. Devon Park Bioventures led the round, and was joined by return backers Rho Ventures, Care Capital, Pitango Venture Capital, MedImmune Ventures and Bio*One Capital. The company previously raised around $75 million.
4 min read · 11 June 2010
Igenica Inc., a developer of antibody-based cancer medicines, has raised $24 million in Series B funding. Return backers include The Column Group, OrbiMed Advisors and 5AM Ventures. The Burlingame, Calif.-based company previously raised just over $5 million.
2 min read · 11 June 2010
1 min read · 11 June 2010
3 min read · 10 June 2010
Collecta, a Los Angeles-based provider of streaming real-time search, has raised $4.7 million in new VC funding. Dace Ventures was joined by return backer True Ventures.
4 min read · 10 June 2010
Quark Pharmaceuticals Inc., a Fremont, Calif.-based developer of RNA interference-based therapeutics, has raised $10 million in new VC funding from existing backer SBI Holdings Group (Japan).
3 min read · 10 June 2010
Ron Laufer, co-founder of Lilly Ventures, has joined MedImmune Ventures as senior managing director.
2 min read · 10 June 2010
Blazent Inc., a San Mateo, Calif.-based provider of IT intelligence for IT outsourcers, has raised $10 million in new VC funding. HighBAR Ventures led the round, and was joined by KeyNote Ventures, Walden Venture Capital and Catamount Ventures. The company previously raised over $28 million from Keynote, Bain Capital Ventures, Benchmark Capital, FirstMark Capital, Brookside Management, SV Life Sciences and StarVest Partners.
2 min read · 10 June 2010
